Jeff Yass’s Artelo Biosciences, Inc. Warrant ARTLW Stock Holding History

Jeff Yass’s Portfolio ARTLW Stock Details ARTLW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-13,786	Closed	-$3K	–	14113
2021 Q3	$3K	Buy	+13,786	New	+$4.01K	﹤0.01%	12630
2021 Q2	–	Sell	-12,402	Closed	-$5K	–	13433
2021 Q1	$5K	Sell	12,402 -15,931	-56%	-$6.66K	﹤0.01%	12162
2020 Q4	$7K	Buy	28,333 +2,891	+11%	+$328	﹤0.01%	10924
2020 Q3	$2K	Buy	25,442 +8,734	+52%	+$1K	﹤0.01%	10456
2020 Q2	$2K	Buy	+16,708	New	+$2.2K	﹤0.01%	10015

Other funds holding ARTLW

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

AGM

Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return

Jeff Yass's ARTLW Position: Q4 2021 in Review

Jeff Yass sold out of Artelo Biosciences, Inc. Warrant (ARTLW) in Q4 2021, closing a stake of 13,786 shares — an estimated $3K sold.

Jeff Yass first reported a position in ARTLW in Q2 2020 and held it in 5 quarters. The position peaked at $7K in Q4 2020. 5 funds tracked by Wall St. Rank hold ARTLW as of Q4 2021.

Jeff Yass reported no remaining Artelo Biosciences, Inc. Warrant position as of Q4 2021 after selling out during the quarter.
Jeff Yass sold 13,786 Artelo Biosciences, Inc. Warrant shares in Q4 2021, an estimated $3K.
Jeff Yass first reported a position in Artelo Biosciences, Inc. Warrant in Q2 2020 and held it in 5 quarters.
Jeff Yass's Artelo Biosciences, Inc. Warrant position peaked at $7K in Q4 2020.
5 funds tracked by Wall St. Rank held Artelo Biosciences, Inc. Warrant as of Q4 2021.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.